cancer therapy
cancer research
cancer community
research community
intrinsic resistance mechanisms
patient specific host driven resistance mechanism
new stream of research
development of Personalised Host Response Diagnostic kit Drug resistance
diagnostic providers
cancer chemotherapy
new paradigm
diagnostic platform Prototype
specific factor
drug manufacturers
markets
drug administration
new PHRD standard
off-the-shelf drugs
Resistant Mechanisms
paradigm shift
lines of treatments
cycles of treatments
tumours relapse
PHRD goal
modern targeted drugs
major reason
groups
pharmaceutical disciplines
formation of special
failure
SHDRM
published papers
clear need
clinical study design report
oncologists
partners
researchers
hours
novel way
ERC
HostResponse
grant
Clinicians
discovery
patients
discussions